bioresorbable scaffold
Showing 1 - 25 of 404
Chronic Limb-Threatening Ischemia Trial (MAGNITUDE Sirolimus-eluting Bioresorbable Scaffold, Percutaneous Transluminal
Not yet recruiting
- Chronic Limb-Threatening Ischemia
- MAGNITUDE Sirolimus-eluting Bioresorbable Scaffold
- Percutaneous Transluminal Angioplasty (PTA)
- (no location specified)
Oct 9, 2023
Critical Limb Ischemia Trial in Saint Helena, Leipzig (MOTIV Sirolimus-Eluting Bioresorbable Scaffold, Percutaneous Transluminal
Recruiting
- Critical Limb Ischemia
- MOTIV Sirolimus-Eluting Bioresorbable Scaffold
- Percutaneous Transluminal Angioplasty (PTA) Device
-
Saint Helena, California
- +1 more
Oct 19, 2022
Infrapopliteal Lesions, Critical Limb Ischemia Trial in Florence (Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold
Recruiting
- Infrapopliteal Lesions
- Critical Limb Ischemia
- Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold System (IBS Titan™)
-
Florence, ItalyAzienda Ospedaliero Universitaria Careggi
Jul 31, 2023
Critical Limb-Threatening Ischemia, Critical Limb Ischemia, Critical Lower Limb Ischemia Trial (MAGNITUDE BRS)
Not yet recruiting
- Critical Limb-Threatening Ischemia
- +2 more
- MAGNITUDE BRS
- (no location specified)
Oct 4, 2023
Coronary Artery Disease, Stable Angina, Coronary Artery Stenosis Trial in Odense (ScoreFlex balloon, Device: standard
Recruiting
- Coronary Artery Disease
- +9 more
- ScoreFlex balloon
- Device: standard non-compliant balloon
-
Odense, DenmarkOdense University Hospital
Nov 30, 2021
Bioresorbable Vascular Scaffold in Routine Clinical Practice
Active, not recruiting
- Arterial Occlusive Diseases
- +3 more
- Bioresorbable Vascular Scaffold
-
Seoul, Songpa-gu, Korea, Republic of
- +13 more
Dec 11, 2022
Peripheral Arterial Disease, Critical Limb Ischemia Trial in Austria, Germany (MOTIV BVS)
Active, not recruiting
- Peripheral Arterial Disease
- Critical Limb Ischemia
- MOTIV BVS
-
Vienna, Austria
- +7 more
Aug 30, 2021
Coronary Artery Disease Trial (MeRes 100 Sirolimus-eluting Bioresorbable Vascular Scaffold System (BRS))
Not yet recruiting
- Coronary Artery Disease
- MeRes 100 Sirolimus-eluting Bioresorbable Vascular Scaffold System (BRS)
- (no location specified)
Jun 10, 2022
Pulmonary Artery Stenosis Trial in China (Iron Bioresorbable Scaffold System (IBS Angel))
Recruiting
- Pulmonary Artery Stenosis
- Iron Bioresorbable Scaffold System (IBS Angel)
-
Changsha, China
- +9 more
Nov 18, 2021
Coronary Artery Disease Trial in Fribourg (Implantation of everolimus-eluting bioresorbable vascular scaffold stent,
Completed
- Coronary Artery Disease
- Implantation of everolimus-eluting bioresorbable vascular scaffold stent
- +2 more
-
Fribourg, SwitzerlandFribourg Cantonal Hospital
Oct 14, 2021
Coronary Artery Disease Trial in Kunming (Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System)
Recruiting
- Coronary Artery Disease
- Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System
-
Kunming, Yunnan, ChinaFuwai Yunnan Cardiovascular Hospital
Mar 16, 2022
Coronary Artery Disease Trial in Kunming (Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System (IBS), Abbott Vascular
Recruiting
- Coronary Artery Disease
- Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System (IBS)
- Abbott Vascular XIENCE Everolimus Eluting Coronary Stent System
-
Kunming, ChinaFuwai Yunnan Cardiovascular Hospital
Mar 16, 2022
Myocardial Infarction, Coronary Artery Disease Trial in Odense (OCT guided PCI, Angiography guided PCI)
Active, not recruiting
- Myocardial Infarction
- Coronary Artery Disease
- OCT guided PCI
- Angiography guided PCI
-
Odense, Region Of Southern Denmark, DenmarkOdense University Hospital
Feb 28, 2021
Single Coronary Vessel Disease Trial in Peking (Sirolimus-eluting Iron Bioresorbable Coronary Scaffold System)
Active, not recruiting
- Single Coronary Vessel Disease
- Sirolimus-eluting Iron Bioresorbable Coronary Scaffold System
-
Peking, ChinaBeijing Fuwai hospital
Sep 10, 2021
IRIS-BVS AMI Registry
Terminated
- Arterial Occlusive Diseases
- +2 more
- Bioresorbable Vascular Scaffold
-
Seoul, Korea, Republic ofAsan Medical Center
Sep 6, 2021
Percutaneous Coronary Intervention, Myocardial Revascularization, Tomography, Optical Coherence Trial in Genk, Leuven, Rotterdam
Recruiting
- Percutaneous Coronary Intervention
- +2 more
- Fantom Encore Bioresorbable scaffold implantation
-
Genk, Belgium
- +2 more
Oct 12, 2020
Cardiac Allograft Vasculopathy Trial in Italy, Netherlands (Everolimus-Eluting Bioresorbable Vascular Scaffold (ABSORB))
Completed
- Cardiac Allograft Vasculopathy
- Everolimus-Eluting Bioresorbable Vascular Scaffold (ABSORB)
-
Cagliari, Italy
- +9 more
Sep 29, 2021
Coronary Artery Disease Trial in Antwerp, Genk, Sao Paulo (DESolve Cx drug eluting coronary scaffold system)
Completed
- Coronary Artery Disease
- DESolve Cx drug eluting coronary scaffold system
-
Antwerp, Belgium
- +2 more
Jul 13, 2021
Rotator Cuff Tears Trial in United States (nanofiber scaffold)
Recruiting
- Rotator Cuff Tears
- nanofiber scaffold
-
Gulf Breeze, Florida
- +5 more
Apr 4, 2022
Critical Limb Ischemia (CLI) Trial in China (Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold System (IBS Titan™),
Recruiting
- Critical Limb Ischemia (CLI)
- Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold System (IBS Titan™)
- Percutaneous Transluminal Angioplasty (PTA) Device
-
Beijing, China
- +28 more
Mar 16, 2022
Coronary Artery Stenosis Trial in Austria, Germany (ABSORB Scaffold)
Completed
- Coronary Artery Stenosis
- ABSORB Scaffold
-
Vienna, Wien, Austria
- +80 more
Mar 31, 2022
Coronary Artery Disease Trial in Austria, Germany, Switzerland (Fantom)
Recruiting
- Coronary Artery Disease
- Fantom
-
Wien, Austria
- +9 more
Apr 20, 2021
Acute Coronary Syndrome, ST Segment Elevation Myocardial Infarction, Stent Trial in Spain (Percutaneous coronary intervention)
Completed
- Acute Coronary Syndrome
- +2 more
- Percutaneous coronary intervention
-
Alicante, Spain
- +10 more
Apr 15, 2020
Critical Limb Ischemia Trial in Singapore (BVS, Abbott Vascular)
Completed
- Critical Limb Ischemia
- BVS, Abbott Vascular
-
Singapore, SingaporeChangi General Hospital
Oct 6, 2020